ArticleBiomedical engineering and computational biology2026
Token-Level Attribution for Transparent Biomedical AI.
Article in Biomedical engineering and computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A highly interpretable machine learning model for predicting lung cancer bone metastasis: uncovering the synergistic effect of routine biochemical markers.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Explainability (xAI) is critical for fostering trust, ensuring safety, and supporting regulatory compliance in healthcare AI systems. Large Language Models (LLMs), with impressive capabilities, operate as "black boxes" with prohibitive computational demands and regulatory challenges. Small Language Models (SLMs) with open-source architectures present a pragmatic alternative, offering efficiency, potential interpretability, and alignment with data privacy frameworks. This study evaluates whether token-level attribution (TLA) methods can provide technical traceability in SLMs for clinical decision support. Methods: The Captum 0.7 attribution library was applied to a Qwen-2.5-1.5B model on 20 breast cancer cases from a publicly available dataset. Hardware requirements were profiled on consumer-grade GPU. Using perturbation-based integrated gradients, we analyzed how clinical input features statistically influenced token generation probabilities. Results: Attribution heatmaps successfully identified clinically relevant input features, with high-attribution tokens corresponding to expected clinical factors. The model occupied minimal storage, enabling local deployment without cloud infrastructure. This validates that SLMs can provide algorithmic traceability required for regulatory frameworks. Conclusions: This proof-of-concept demonstrates the technical feasibility of combining SLMs with perturbation-based xAI methods to achieve auditable clinical AI within practical hardware constraints. While TLA provides statistical associations, bridging toward causal clinical reasoning requires further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.